BioCentury
ARTICLE | Company News

Metabasis, Roche deal

June 15, 2009 7:00 AM UTC

Metabasis received a $2 million milestone payment from Roche under a 2008 research deal to apply Metabasis' HepDirect liver-targeting technology to undisclosed nucleosides from Roche to treat HCV. The...